EUVIMEDEUVIMED entdecken
Crossref

Familial dysautonomia: Detection of the IKBKAP IVS20 +6T → C and R696P mutations and frequencies among Ashkenazi Jews

Jianli Dong, Lisa Edelmann, Asghar M Bajwa, Ruth Kornreich, Robert J Desnick

American Journal of Medical Genetics · 2002-07 · 110 (3) · 253-257

DOI: 10.1002/ajmg.10450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics, online erschienen am 30.05.2002. Verfasst von Jianli Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Mount Sinai School of Medicine of New York University, New York, New York 10029, USA. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NCRR NIH HHS, NICHD NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy that occurs almost exclusively in the Ashkenazi Jewish (AJ) population. Mutations in the IκB kinase complex‐associated protein ( IKBKAP ) gene cause FD. Two IKBKAP mutations, IVS20 +6T → C and R696P, have been identified in FD patients of AJ descent. The splice site mutation IVS20 +6T → C is responsible for > 99.5% of known AJ patients with FD, and haplotype analyses were consistent with a common founder. In contrast, the R696P mutation has been identified in only a few AJ patients. To facilitate carrier detection, a single PCR and allele‐specific oligonucleotide (ASO) hybridization assay was developed to facilitate the detection of both the IVS20 +6T → C and R696P mutations. Screening of 2,518 anonymous AJ individuals from the New York metropolitan area revealed a carrier frequency for IVS20 +6T → C of 1 in 32 (3.2%; 95% CI, 2.5–3.9%), similar to the previously estimated carrier frequency (3.3%) based on disease incidence. No carrier was identified for the R696P lesion, indicating that the mutation was rare in this population (< 1 in 2,500). This sensitive and specific assay should facilitate carrier screening for FD mutations in the AJ community, as well as postnatal diagnostic testing. © 2002 Wiley‐Liss, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingCarrier ProteinsDNADysautonomia, FamilialGene FrequencyGenetic TestingHeterozygoteJewsMutationMutation, MissenseNew YorkPolymerase Chain ReactionTranscriptional Elongation Factors

Substanzen

Carrier ProteinsElp1 protein, humanTranscriptional Elongation FactorsDNA

Autor:innen und Institutionen

  • Department of Human Genetics, Mount Sinai School of Medicine of New York University, New York, New York 10029, USA.

Förderung

  • NCRR NIH HHS
  • NICHD NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Dong, J., Edelmann, L., Bajwa, A. M., Kornreich, R., & Desnick, R. J. (2002). Familial dysautonomia: Detection of the IKBKAP IVS20 +6T → C and R696P mutations and frequencies among Ashkenazi Jews. American Journal of Medical Genetics, 110(3), 253-257. https://doi.org/10.1002/ajmg.10450

Vancouver

Dong J, Edelmann L, Bajwa AM, Kornreich R, Desnick RJ. Familial dysautonomia: Detection of the IKBKAP IVS20 +6T → C and R696P mutations and frequencies among Ashkenazi Jews. American Journal of Medical Genetics. 2002;110(3):253-257. doi:10.1002/ajmg.10450

BibTeX
@article{Dong2002,
  author = {Dong, Jianli and Edelmann, Lisa and Bajwa, Asghar M and Kornreich, Ruth and Desnick, Robert J},
  title = {Familial dysautonomia: Detection of the IKBKAP IVS20 +6T → C and R696P mutations and frequencies among Ashkenazi Jews},
  journal = {American Journal of Medical Genetics},
  year = {2002},
  volume = {110},
  number = {3},
  pages = {253--257},
  doi = {10.1002/ajmg.10450}
}
Kostenlos starten →